Panic Disorder
What is panic disorder? Panic disorder occurs when you experience recurring unexpected panic attacks. The DSM-5 defines panic attacks as abrupt surges of intense fear or discomfort that peak within minutes. People with the disorder live in fear of having a panic attack.
Cluster Number:
Wiki Number: PW150
Diagnosis: Panic Disorder
US Patients: 2.5% sometime in life
World Patients:
Sex Ratio: M;W2
Age Onset: adolescence or early adulthood
Brain Area: amygdala, anterior cingulate cortex, hippocampus and periaqueductal grey may all be autonomically stimulated and frightening extent
Symptoms: 1-5 or up to 20 minute duration; rapid heartbeat, dizziness, fear of losing control, going crazy or dying; choking, paralysis and others.
Progression: Treatment helps 50%, but 30% have recurrences.
Causes: PTSD, taking on too much responsibility, genetic, substance abuse-drug or alcohol;
Medications: Antidepressants, benzodiazopines, beta blockers
Therapies: learning positive self-talk helps to reduce the panic; reductions can occur within twelve weeks.
Youtube Video: Panic Attacks vs. Panic Disorder
Amazon or Library Book:
The Cognitive Behavioral Therapy Workbook for Panic Attacks
Click the book to link or order from Amazon.
Support Group: mhanational.org; 800-273-8255
(Mental Health America)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Pharmacogenetic Testing in Treatment-resistant Panic Disorder: a Preliminary Analysisby Marcos Fidry on January 22, 2025
CONCLUSION: Commercial pharmacogenetic testing failed to predict negative treatment outcome in most patients with PD. The association between treatment-resistance in PD and the genes CYP2C19, MTHFR and ABCB1 deserves further study.
- Concomitant pheochromocytoma and hyperaldosteronism in a 47-year-old man: a case reportby Fatemeh Majidi on January 18, 2025
CONCLUSION: This case highlights the importance of considering rare coexisting endocrine disorders in patients presenting with hypertension. Appropriate diagnosis and management of concomitant pheochromocytoma and hyperaldosteronism are crucial for favorable outcomes and may offer insights into potential overlaps in disease pathways.
- Meta-analysis of prospective longitudinal cohort studies on the impact of childhood traumas on anxiety disordersby Jingjing Liu on January 17, 2025
CONCLUSIONS: This meta-analysis underscores that childhood trauma exposure significantly increases the risk of anxiety disorders across different age groups and types of anxiety disorders. Various forms of childhood trauma, including maternal dysfunction, paternal dysfunction, physical abuse, sexual abuse, emotional abuse and bullying, are consistently associated with later development of anxiety disorders, highlighting the importance of early intervention and support in preventing anxiety...
- Panic disorder during pregnancy and the first three years after delivery: a systematic reviewby F Gerrik Verhees on January 17, 2025
CONCLUSION: Heterogenous courses and outcomes of peripartum PD require comprehensive monitoring of affected mothers and their infants. There is a need for further longitudinal investigations into familial transmission of anxiety disorders.